{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:41:13Z","timestamp":1784346073474,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.115933","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:31:59Z","timestamp":1699601519000},"page":"115933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Synthesis and structure-activity optimization of hydroxypyridinones against rhabdomyolysis-induced acute kidney injury"],"prefix":"10.1016","volume":"263","author":[{"given":"Jie","family":"Cen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-3679","authenticated-orcid":false,"given":"Wenteng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115933_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00415-019-09185-4","article-title":"A systematic review on the definition of rhabdomyolysis","volume":"267","author":"Stahl","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejmech.2023.115933_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115933_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejmech.2023.115933_bib4","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2174\/092986705774463021","article-title":"Hemoglobin and myoglobin associated oxidative stress: from molecular mechanisms to disease States","volume":"12","author":"Reeder","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2023.115933_bib6","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1681\/ASN.2019060595","article-title":"Iron chelation as a potential therapeutic strategy for AKI prevention","volume":"30","author":"Sharma","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2023.115933_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI115942","article-title":"Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications","volume":"90","author":"Zager","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115933_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1042\/BJ20101728","article-title":"Comparing the potential renal protective activity of desferrioxamine B and the novel chelator desferrioxamine B-N-(3-hydroxyadamant-1-yl)carboxamide in a cell model of myoglobinuria","volume":"435","author":"Groebler","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.115933_bib9","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41467-019-13143-z","article-title":"Renal clearable nanochelators for iron overload therapy","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115933_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115933_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/acschembio.2c00914","article-title":"Targeting labile iron-mediated ferroptosis provides a potential therapeutic strategy for rhabdomyolysis-induced acute kidney injury","volume":"18","author":"Zhu","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115933_bib12","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1021\/acs.jmedchem.0c01480","article-title":"Hydroxypyridinone-based iron chelators with broad-ranging biological activities","volume":"63","author":"Jiang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/jm049306x","article-title":"Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance","volume":"48","author":"Bergeron","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib14","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1021\/jm0508944","article-title":"(S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity","volume":"49","author":"Bergeron","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/cbdd.12358","article-title":"Design, synthesis, and antimicrobial evaluation of hexadentate hydroxypyridinones with high iron(III) affinity","volume":"84","author":"Zhang","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115933_bib16","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/acs.jmedchem.0c00137","article-title":"CN128: a new orally active hydroxypyridinone iron chelator","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acs.jmedchem.6b00935","article-title":"Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets","volume":"60","author":"Liu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bmcl.2017.07.001","article-title":"Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy","volume":"28","author":"Chen","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115933_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2023.115933_bib20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1021\/acs.orglett.1c03833","article-title":"Boronic-acid-accelerated electrophilic activation of unprotected maltols to N-substituted hydroxypyridinones in water","volume":"24","author":"Ke","year":"2022","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.115933_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202679","article-title":"New deferric amine compounds efficiently chelate excess iron to treat iron overload disorders and to prevent ferroptosis","volume":"9","author":"Feng","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2023.115933_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115933_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2021.05.010","article-title":"Baicalein inhibits RLS3-induced ferroptosis in melanocytes","volume":"561","author":"Yang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115933_bib24","series-title":"Metal Chelation in Medicine","author":"Crichton","year":"2016"},{"key":"10.1016\/j.ejmech.2023.115933_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0009-2797(82)90018-7","article-title":"Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical","volume":"41","author":"Hoe","year":"1982","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115933_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"Erel","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejmech.2023.115933_bib27","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1016\/j.bmc.2013.07.051","article-title":"Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers","volume":"21","author":"Tang","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib28","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1021\/acs.jmedchem.8b01596","article-title":"Small-molecule modulators of the hypoxia-inducible factor pathway: development and therapeutic applications","volume":"62","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","article-title":"Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function","volume":"10","author":"Li","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2023.115933_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cmet.2016.01.002","article-title":"HIF-1\u03b1 promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival","volume":"23","author":"Stegen","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2023.115933_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103913","article-title":"Effectiveness of deferiprone-loaded nanocarrier in experimentally induced rhabdomyolysis: a dose-comparison study","volume":"100","author":"Rashed","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115933_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126798","article-title":"Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice","volume":"67","author":"Ikeda","year":"2021","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.ejmech.2023.115933_bib33","first-page":"239","article-title":"A review on iron chelators in treatment of iron overload syndromes","volume":"10","author":"Mobarra","year":"2016","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.ejmech.2023.115933_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmcl.2003.11.005","article-title":"Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors","volume":"14","author":"Nakamura","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:55:09Z","timestamp":1759330509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423009005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0223523423009005"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115933","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and structure-activity optimization of hydroxypyridinones against rhabdomyolysis-induced acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115933"}}